Vice President, Scientific Affairs, The Feinstein Institute for Medical Research
Executive Editor, Molecular Medicine, Boas Marks Pavilion
Christopher J. Czura, PhD, is vice president of the Feinstein Institute for Medical Research, executive publisher of the Feinstein Institute Press’ international, peer-reviewed journals Molecular Medicine and Bioelectronic Medicine, executive producer of the Merinoff Conference Series, and chief financial officer for the Elmezzi Graduate School of Molecular Medicine. Dr. Czura provides oversight of the Institute’s daily operations and $95 million annual budget. He collaborates with the president of the Institute to develop and execute strategic plans, and is committed to building successful programs that nurture the collaborative and interactive environment of the Feinstein Institute. He leads project teams in the design and oversight of construction of new laboratory facilities and renovation projects.
A molecular biologist by training, Dr. Czura’s research interests focus on autonomic neural regulation of hemostasis and inflammation. He received his B.S. in biotechnology from William Paterson University in 1996 and a doctoral degree in molecular microbiology from Stony Brook University in 2009. He is author or co-author of approximately 80 peer-reviewed publications, book chapters and meeting abstracts, and co-inventor on a patent that describes vagus nerve stimulation to control hemorrhage.
Dr. Czura began his research career in the laboratory of Kevin J. Tracey, MD, studying the mechanisms of pathological inflammation. His early work focused on validating HMGB1 as a therapeutic target, and gaining a broader understanding of its molecular mechanisms of disease pathogenesis. Dr. Czura has also studied the inflammatory reflex, a neural mechanism through which the central nervous system detects and regulates immune responses to infection and injury.
More recently, Dr. Czura and his colleagues Kevin J. Tracey, MD, and Jared Huston, MD, have made discoveries in the field of bioelectronic medicine, a new field of technology that uses electrical impulses to regulate neural activity to cure disease. His primary work in this field led to the discovery of the “neural tourniquet,” a field of technology that uses electrical nerve stimulation to control traumatic hemorrhage. Dr. Czura’s current research focuses on the molecular mechanisms of the neural tourniquet, and the development of new devices to activate this novel mechanism to control bleeding.